Compared with non‐s‐HT patients, those with s‐HT had lower levels of vWF (26.57 [13.64–37.18] vs. 42.00 [26.02–55.52] ng/mL, p < 0.001) and could be efficiently distinguished from ischemic stroke patients (AUC = 0.735, p < 0.001). This evidence concerns the gene VWF and hematocrit.